EVGN - Evogene Ltd.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
3.83
+0.09 (+2.41%)
At close: 3:56PM EST
Stock chart is not supported by your current browser
Previous Close3.74
Open3.71
Bid0.01 x 100
Ask7.55 x 100
Day's Range3.71 - 4.00
52 Week Range3.60 - 5.86
Volume12,513
Avg. Volume20,175
Market Cap94.76M
Beta0.38
PE Ratio (TTM)N/A
EPS (TTM)-0.83
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.00
Trade prices are not sourced from all markets
  • GlobeNewswire16 days ago

    Evogene Financial Results for the Third Quarter of 2017 Earnings Announcement Schedule

    REHOVOT, Israel, Nov. 02, 2017-- Evogene Ltd., a leading biotechnology company developing novel products for life science markets through the use of a unique computational predictive biology platform, ...

  • GlobeNewswire19 days ago

    Evogene Announces Revised and Expanded Market Focus and New Corporate Structure

    REHOVOT, Israel, Oct. 30, 2017-- Evogene Ltd., a leading biotechnology company developing novel products for life science markets through the use of a unique computational predictive biology platform, ...

  • Capital Cubelast month

    ETFs with exposure to Evogene Ltd. : October 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Evogene Ltd. Here are 5 ETFs with the largest exposure to EVGN-US. Comparing the performance and risk of Evogene Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Evogene Ltd. :EVGN-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017
    Capital Cubelast month

    Evogene Ltd. :EVGN-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017

    Categories: Yahoo FinanceGet free summary analysis Evogene Ltd. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 1.18 million, Net Earnings of USD -4.74 million. Gross margins widened from 12.89% to 13.58% compared to the same period last year, operating (EBITDA) margins now -392.28% from -254.20%. Change in operating cash ... Read more (Read more...)

  • GlobeNewswire2 months ago

    Evogene & Rahan Meristem announce positive results in 2nd year field trials addressing Black Sigatoka disease in banana and the utilization of the results for genome editing

    REHOVOT and ROSH HANIKRA, Israel, Sept. 26, 2017-- Evogene Ltd., a leading company for the improvement of crop productivity, and Rahan Meristem Ltd., a leading fruit biotechnology and breeding company, ...

  • GlobeNewswire3 months ago

    Evogene to Present at the 26th Asian-Pacific Weed Science Society Conference

    REHOVOT, Israel, Aug. 23, 2017-- Evogene Ltd.,, a leading company for the improvement of crop productivity, announced today that the R&D director of its Ag-Chemicals activity area, Dr. Boaz Inbal, will ...

  • Associated Press3 months ago

    Evogene reports 2Q loss

    The Rehovot, Israel-based company said it had a loss of 18 cents per share. The agricultural company posted revenue of $1.2 million in the period. Evogene shares have decreased almost 1 percent since the ...

  • Zacks4 months ago

    Company News for July 12, 2017

    Companies in the News are: FOLD,SLP,ARNA,EVGN,MON

  • Capital Cube5 months ago

    ETFs with exposure to Evogene Ltd. : July 4, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Evogene Ltd. Here are 5 ETFs with the largest exposure to EVGN-US. Comparing the performance and risk of Evogene Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Evogene Ltd. :EVGN-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017
    Capital Cube6 months ago

    Evogene Ltd. :EVGN-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017

    Categories: Yahoo FinanceGet free summary analysis Evogene Ltd. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Evogene Ltd. – E. I. du Pont de Nemours and Company, 22nd Century Group, Inc., Compugen Ltd. and Dow Chemical Company (DD-US, XXII-US, CGEN-US and DOW-US) that have also ... Read more (Read more...)

  • Associated Press6 months ago

    Evogene reports 1Q loss

    The Rehovot, Israel-based company said it had a loss of 19 cents per share. The agricultural company posted revenue of $721,000 in the period. Evogene shares have risen slightly more than 1 percent since ...

  • Associated Press9 months ago

    Evogene reports 4Q loss

    On a per-share basis, the Rehovot, Israel-based company said it had a loss of 26 cents. The agricultural company posted revenue of $1.2 million in the period. For the year, the company reported that its ...